BNP Paribas Financial Markets
CRTX

BNP Paribas Financial Markets’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

BNP Paribas Financial Markets’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-213
Closed -$2.02K – 4225
2013
Q4 		$2.02K Buy
+213
New +$2.02K ﹤0.01% 3647

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

BNP Paribas Financial Markets's CRTX Position: Q1 2014 in Review

BNP Paribas Financial Markets sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 213 shares — an estimated $2.02K sold.

BNP Paribas Financial Markets first reported a position in CRTX in Q4 2013 and held it in 1 quarter. The position peaked at $2.02K in Q4 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • BNP Paribas Financial Markets reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 213 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $2.02K.
  • BNP Paribas Financial Markets first reported a position in CORNERSTONE THERAPEUTICS INC in Q4 2013 and held it in 1 quarter.
  • BNP Paribas Financial Markets's CORNERSTONE THERAPEUTICS INC position peaked at $2.02K in Q4 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2014, filed 13 May 2014.